16
October

08:00 AM BST

Medicinal Chemistry

Name: Medicinal Chemistry Strategy Meeting Europe 2025
Start: 2025-10-22T08:00
End: 2025-10-22T18:00
Location: Crowne Plaza, London Docklands

Strategy Meeting Europe 2025

Reinvigorating Productivity in Pharma & Biotech R&D Through Advanced Technologies and Innovative Techniques that Interrogate Activity and Mechanisms

Crowne Plaza London Docklands

Our Event Starts In

–
days

–
hours

–
minutes

–
seconds

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Medicinal Chemistry Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered. Proventa International’s R&D Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Medicinal Chemistry professionals from across Europe, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across Europe, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We've partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Meet Our Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Past Medicinal Chemistry strategy meeting.

Amrik Mahal

Global Head of IT for Research AstraZeneca

Chandan Seth Nanda

Vice President of Target & Drug Discovery Pear Bio

Spearheading innovation at Pear Bio as Vice President of Target & Drug Discovery, her journey weaves a narrative of precision in oncology drug discovery. With a focus on early-phase drug discovery, HIT and LEAD identification, and biomarker integration, her expertise lays the groundwork for transformative cancer therapies. The strategic roadmap she helped develop for small biopharma positions Pear Bio at the forefront of the competitive oncology landscape. 
Her tenure with Pear Bio has been marked by the successful inception of drug discovery programs and securing substantial Series A funding, highlighting their company’s ascent in precision medicine. Collaboratively working with KOLs and CROs, she contributed to the success of Pear Bio as a companion diagnostics and targeted drug discovery company. In conjunction with our team, she is committed to delivering precision cancer therapeutics, fostering novel assets, and amplifying opportunities for the company.

Daniel Gironés

Managing Director Sapiens Natura Pharma

Guido Koch

Chief Executive Officer Amphilix

Guido Koch is a board member of SynpleChem and co-founder and CEO of <a href="https://www.amphilix.com/">Amphilx</a>. From 2018 to 2020, Guido was the COO of Topadur Pharma and before a Director in Global Discovery Chemistry at Novartis.
During his career in drug discovery and development, Guido has lead projects in different phases from target identification to early clinical stage including multiple kinase inhibitors. Highlights from >20 years of experience in pharmaceutical industry include significant contributions to one marketed product and 8 clinical candidates.
Guido has built a strong network with academia and the CRO community, which allows him to support research programs by external knowledge, new technology and resources. His research has culminated in >45 scientific publications and 10 patent applications.
Educated at ETH Zürich, he received his Diploma in Chemistry and Biochemistry in 1991, followed from a PhD from the University of Basel. After a postdoc at Caltech, he joined Novartis in 1997.

Idlir Liko

Founder OMass Therapeutics

Thierry Dorval

Head of Data Sciences & Data Management Servier Pharma

Our Agenda

See Which Topics Are Discussed at the Strategy Meeting

08:30 - 09:00

09:00 - 10:00

Roundtable Tracks

AI/ML
Generative Chemistry in Action: Applications, Challenges, and Breakthroughs

Chemical Biology, Targeted Protein Degradation u0026 Undruggables
Beyond the Degradation Mechanism: Addressing Safety and Formulation in Targeted Therapeutics

Hit Identification/Lead Optimization
Fragment Based Drug Discovery (Topic TBC)

-Idlir Liko
Founder
OMass Therapeutics

Strategic Partnerships In Drug Discovery
How does biotech and pharma react to the geopolitcal changes and how does this affect collaboration and partnering strategies

-Guido Koch
Chief Executive Officer
Amphilix

Integrated Drug Discovery
From Hit to Lead: Accelerating Drug Discovery Through Cutting-Edge Chemistry and Innovative Screening Strategies (Topic TBC)

-Daniel Gironés
Managing Director
Sapiens Natura Pharma

11:10 - 12:10

Roundtable Tracks

AI/ML
Emerging Challenges in Machine Learning (ML) -Driven Molecular Property Predictions

Sponsor

Chemical Biology, Targeted Protein Degradation u0026 Undruggables
Chemoproteomics: Probing Small Molecules’ Interactions with Complex Biological Systems

Revvity Signals

Hit Identification/Lead Optimization
Fragment Based Drug Discovery in the Spotlight: Emerging Trends in Hit Identification and Lead Optimization

Sponsor

Strategic Partnerships In Drug Discovery
How Strategic Partnerships Revolutionize Pharma R&D

Sponsor

Integrated Drug Discovery
AI/ML Integration in the Discovery and Development of Next-Generation Therapeutics

Revvity Signals

12:15 - 13:15

Roundtable Tracks

AI/ML
The Evolution of AI: Looking Back at the Past 10 years and Projecting the Future 10 (Topic TBC)

-Thierry Dorval
Head of Data Sciences & Data Management
Servier Pharma

Chemical Biology, Targeted Protein Degradation u0026 Undruggables
Emerging “Undruggable” Targets in Targeted Protein Degradation

Hit Identification/Lead Optimization
Drugging Protein:Protein Interactions: Best practices in hit identification and lead optimization of undruggable complexes

Strategic Partnerships In Drug Discovery
Strategic Alliances and Investment Strategies: Fueling the Future of Drug Discovery

-Chandan Seth Nanda
Vice President of Target & Drug Discovery
Pear Bio

Integrated Drug Discovery
The Next Frontier in Therapeutic RNA: Exploring Computational and AI-Driven Approaches for Target Identification, mRNA Synthesis, and Small Molecule Integration

14:40 - 15:10

15:10 - 16:10

Roundtable Tracks

AI/ML
Explainable AI (XAI) and ML/AL as assistive intelligence to support rational lead optimization of small molecules (Topic TBC)

-Amrik Mahal
Global Head of IT for Research
AstraZeneca

Chemical Biology, Targeted Protein Degradation u0026 Undruggables
From Discovery to Application: Challenges in Using Chemical Probes for Degrader Development

Hit Identification/Lead Optimization
AI-Driven Drug Discovery: Transforming Hit Identification and Lead Optimization

Strategic Partnerships In Drug Discovery
The Role of Venture Partnerships in Drug Discovery

Integrated Drug Discovery
Blood-Brain Barrier Penetration in Drug Discovery - Challenges, Innovations, and Future Directions

16:30 - 17:00

See the full agenda and facilitator line-up

Download the strategy meeting brochure for full details

DOWNLOAD THE BROCHURE

Reasons To Attend Our Strategy Meetings

Fully Interactive Format

There's only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter

Senior Decision Makers

All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Personalised Agendas

Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we'll create a personalised agenda just for you

Private and Intimate Networking

Small group discussions, private meetings, networking drinks - however you choose to make those important connections our Strategy Meetings have the solution

Become an official strategy meeting partner

Whatever your business needs, we can help. Get in touch for partnering opportunities

I'D LIKE TO PARTNER

Explore Highlight From The Past Events

Gain valuable insights, discover innovative solutions and connect with industry leaders through snapshots of our most successful gatherings.

Oct
2024

Jun
2022

Press play to hear what your colleagues had to say...

Hotel & Venue

Crowne Plaza London Docklands

Our hotel is a haven from the hustle & bustle of London life - you’ll find peace & tranquility in modern surroundings. We’re close to The O2 Arena, ExCeL Exhibition Centre & Canary Wharf.

Hotel Details Map & Directions Parking

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

R&D Europe

Bioinformatics & Drug Discovery Biology Strategy Meeting Europe 2025

Medicinal Chemistry

Strategy Meeting Europe 2025

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Crowne Plaza London Docklands

Fresh Medicinal Chemistry Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Meet Our Facilitators

Amrik Mahal

Chandan Seth Nanda

Daniel Gironés

Guido Koch

Idlir Liko

Thierry Dorval

Our Agenda

See Which Topics Are Discussed at the Strategy Meeting

BREAKFAST & REGISTRATION

Opening Keynote

Roundtable ( Pharma/Biotech )

Roundtable Tracks

Refreshment Break

Networking/1-1 Meetings

Roundtable ( Solutions )

Roundtable Tracks

Sponsor

Revvity Signals

Sponsor

Sponsor

Revvity Signals

Rountable Discussion ( Pharma/Biotech )

Roundtable Tracks

Networking Lunch

Networking/1-1 Meetings

Afternoon Keynote Presentation

Roundtable ( Pharma/Biotech )

Roundtable Tracks

Afternoon Refreshment Break

Panel Discussion

Drinks & Canapes Reception

See the full agenda and facilitator line-up

Reasons To Attend Our Strategy Meetings

Fully Interactive Format

Senior Decision Makers

Personalised Agendas

Private and Intimate Networking

Our 2025 Sponsors

Co-Host Sponsors

Partnering Sponsors

Media Partner

Become an official strategy meeting partner

Explore Highlight From The Past Events

Press play to hear what your colleagues had to say...

Hotel & Venue

Crowne Plaza London Docklands

Want to find out more?

Here To Help

Select days you wish to attend You can add multiple days

Daily Delegate Rate includes:

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Crowne Plaza London Docklands